Martin, Lainie P <br/><br/>
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.  [electronic resource] 

 -  Gynecologic oncology  11 2017 
 - 402-407 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2017.08.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Carcinoma, Ovarian Epithelial<br/>Female<br/>Folate Receptor 1--biosynthesis<br/>Humans<br/>Immunoconjugates--administration & dosage<br/>Maytansine--administration & dosage<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Ovarian Neoplasms--drug therapy